Imago BioSciences, Inc.
CIK 0001623715
Revenue (TTM)
—
Q3 Nov 2022
Net Income (TTM)
−$58.58M
−137.3% YoY
Q3 Nov 2022
EPS Diluted (TTM)
−$9.48
Q3 Nov 2022
Gross Margin
—
Q3 Nov 2022
Operating Margin
—
Q3 Nov 2022
Net Margin
—
Q3 Nov 2022
Free Cash Flow (TTM)
−$39.77M
Q3 Nov 2022
Cash
$7.29M
Q3 Nov 2022
Total Debt
—
Q3 Nov 2022
Shares Outstanding
33.82M sh
Q3 Nov 2022
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.